Health Products

Viokace (2017-12-05)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
160229AViokace
Recalling Firm
Allergan Inc.
85 Enterprise Blvd, Suite 500
Markham
L6G 0B5
Ontario
CANADA
Marketing Authorization Holder
Aptalis Pharma Canada ULC
TabletDIN 02230019Lipase 10,440 USP units

Introduction

Affected products

Viokace

Reason

Out of specification for enzyme profile during stability testing in affected lot.

Depth of distribution

Wholesalers and pharmacies across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime